- To prescribe long-acting β2 agonists (LABAs) only with inhaled corticosteroids (ICS) and when ICS alone fail to control asthma symptoms.
- Not to initiate LABA treatment in patients with rapidly deteriorating asthma.
- To use the lowest effective dose, review treatment regularly, and discontinue if there is no benefit.
- To consider stepping-down when good long-term asthma control is achieved.
- Not to prescribe LABA for exercise-induced asthma without regular ICS (a short-acting β2-agonist should be used instead).
- To prescribe combination inhalers when appropriate.
See the MIMS summary of BTS/SIGN asthma guidelines for more information.